Differentiating early-stage nasopharyngeal carcinoma from adenoidal hypertrophy via SLC40A1 expression and developing a prognostic model for disease progression

SLC40A1 is significantly downregulated in NPC and may serve as a diagnostic and prognostic biomarker, especially when combined with EBV status.

Authors

Institutions

Publication Details

Journal
American Journal of Cancer Research
Published
2025-01-01
DOI
https://doi.org/10.62347/zbih5385
Primary Topic
Salivary Gland Tumors Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Differentiating early-stage nasopharyngeal carcinoma from adenoidal hypertrophy via SLC40A1 expression and developing a prognostic model for disease progression

Hongwei Wang
American Journal of Cancer Research
Salivary Gland Tumors Diagnosis and Treatment
article

Differentiating early-stage nasopharyngeal carcinoma from adenoidal hypertrophy via SLC40A1 expression and developing a prognostic model for disease progression

Hongwei Wang
article en

Abstract

SLC40A1 is significantly downregulated in NPC and may serve as a diagnostic and prognostic biomarker, especially when combined with EBV status.

American Journal of Cancer ResearchVol. 15(8)
Hebei Eye Hospital (CN)
Good health and well-being
Openalex Percentile: Top 63%
Salivary Gland Tumors Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Differentiating early-stage nasopharyngeal carcinoma from adenoidal hypertrophy via SLC40A1 expression and developing a prognostic model for disease progression — Hongwei Wang · American Journal of Cancer Research (2025) | TGRS Research Map | TGRS